PGI21 a Comparison of the Cost-Effectiveness of Fidaxomicin, Metronidazole, and Vancomycin, in the Treatment of Clostridium Difficile-Associated Disease
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.748
https://www.valueinhealthjournal.com/article/S1098-3015(12)00813-3/fulltext
Title :
PGI21 a Comparison of the Cost-Effectiveness of Fidaxomicin, Metronidazole, and Vancomycin, in the Treatment of Clostridium Difficile-Associated Disease
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00813-3&doi=10.1016/j.jval.2012.03.748
First page :
A138
Section Title :
Gastrointestinal Disorders
Open access? :
No
Section Order :
222